Compound class
Cosmetic and copper peptides
Copper peptides, cosmetic ingredients and melanocortin peptides.
GHK-Cu is the copper form of GHK, a small tripeptide present in human plasma,1 and argireline is a six-amino-acid peptide identified through a rational design programme.2 A 2026 review says formal absorption, distribution, metabolism and excretion studies of the intact GHK-Cu complex have not been reported.3 The class also holds melanocortin peptides. The TGA says no melanotan II product is approved for supply in Australia, and its testing of seized nasal sprays found inconsistent amounts of melanotan II between bottles, which it says increases the chance of adverse events.4 FDA approved bremelanotide (PT-141) as Vyleesi in 2019,5 for premenopausal women with acquired, generalized hypoactive sexual desire disorder.6
Copper and healing peptides 4
-
GHK-Cu
Copper peptide
- Half-life
- Not stated
- Given
- Twice daily on facial skin in one study (topical)
- Form or status
- No product label among its sources
-
AHK-Cu
Copper peptide
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
GHK (Tripeptide-1)
Tripeptide
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
KPV + GHK-Cu
Blend
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
Tanning and cosmetic 10
-
Melanotan II
Melanocortin agonist
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- TGA: no product approved for supply in Australia
-
Argireline
Cosmetic neuropeptide
- Half-life
- Not stated
- Given
- Twice daily in studies
- Form or status
- No product label among its sources
-
Leuphasyl
Cosmetic neuropeptide
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
Matrixyl 3000
Cosmetic matrikine peptide
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
Matrixyl Synthe'6
Cosmetic matrikine peptide
- Half-life
- Not stated
- Given
- Once daily in studies
- Form or status
- No product label among its sources
-
Melanotan I
Melanocortin peptide
- Half-life
- About 15 hours (Scenesse implant)
- Given
- One implant every 2 months (Scenesse label)
- Form or status
- US label for the Scenesse implant, in EPP
-
PT-141
Melanocortin agonist
- Half-life
- About 2.7 hours
- Given
- Not stated
- Form or status
- US label for HSDD in premenopausal women (Vyleesi)
-
SNAP-8
Cosmetic neuropeptide
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
-
Syn-Ake
Cosmetic neuropeptide
- Half-life
- Not stated
- Given
- Twice daily in studies
- Form or status
- No product label among its sources
-
Syn-Coll
Cosmetic matrikine peptide
- Half-life
- Not stated
- Given
- Not stated
- Form or status
- No product label among its sources
Guides 6
- AHK-Cu dosage: mixing and syringe unitsThe searches returned no AHK-Cu label or human dosing trial. A 50mg vial worked out in syringe units, the one registry entry, and what is unknown.
- GHK-Cu and KPV blend dosage: listed strengths and evidenceSearches found no label or human trial dose for a GHK-Cu and KPV blend. Vendor blend strengths, and a syringe example for a KPV-only vial of 10 mg in 2 mL.
- GHK-Cu injection dosage: logged 50 and 100 mg vial setupsLogged GHK-Cu vial sizes, mixes, syringe arithmetic and schedules, and the limits of the human evidence: no label or trial gives an injected vial dose.
- Melanotan 1 dosage: mixing and unitsMelanotan I trial doses in mg/kg, the 16 mg Scenesse implant label, and what the sources leave open on vial strength, water and syringe units.
- Melanotan 2 dosage: mixing a 10 mg vial and unitsNo US label sets a melanotan II dose. Trial doses in mg/kg, how a 10 mg vial mixed with 2 mL reads in units, and what people log.
- PT-141 dosage: the Vyleesi autoinjector and vial arithmeticThe Vyleesi label's fixed dose, the dose in each trial by arm, storage, and vial arithmetic for PT-141 powder in syringe units.
Calculators 5
- AHK-Cu calculator: vials, water and unitsUnits on a U-100 syringe for AHK-Cu: enter the powder in your vial, the water you add and your dose, in mg or mcg, to see the mark.
- GHK-Cu dosage calculator: 50 and 100 mg vialsUnits on a U-100 syringe for GHK-Cu: enter your vial, water and dose, or print the chart for 10, 50 and 100 mg vials.
- Melanotan 1 dosage calculator: vials, water and unitsUnits on a U-100 syringe for melanotan I: enter the powder in your vial, the water you add and your dose, in mg or mcg, to see the mark.
- Melanotan 2 dosage calculator: 10 mg vialUnits on a U-100 syringe for melanotan II: enter your vial, water and dose, or print the chart for 10 mg vials. Starts at the setup Milligram users log most.
- PT-141 dosage calculator: 10 mg vialUnits on a U-100 syringe for PT-141 (Bremelanotide): enter the powder in your vial, the water you add and your dose, in mg or mcg, to see the mark.
Compare 2
- GHK-Cu vs AHK-CuGHK-Cu and AHK-Cu compared on what each copper peptide is, how each is used, what is known of half-life, studied doses and status, with sources.
- Melanotan 1 vs melanotan 2Melanotan 1 (afamelanotide) and melanotan 2 compared on what each peptide is, how each comes, half-life, studied doses and status, with sources.
Logged in Milligram
Share of people who logged a dose in Milligram in the 90 days to 15 November 2026 who logged each compound.
GHK-Cu, how often
Melanotan II, how often
How often: among people with three or more logged doses, by the average gap between their doses.
Aggregated and anonymous, shares of people only. Each compound not listed: too few people logged it to show a share. It describes what people set up in the app, not advice on what to take.
References 11
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. 2018. PMC6073405
- Blanes-Mira C, et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. 2002. PMID 18498523
- Mateescu DM, Gavrilescu DM, Mincioaga RI, et al. GHK-Cu as a Bioactive Metallopeptide and Drug-Delivery Cargo: Coordination Chemistry, Formulation Science, Therapeutic Evidence, and a Translational Roadmap. 2026. PMC13610439
- Therapeutic Goods Administration (Australia). Melanotan II tanning peptide products found to be inconsistently dosed (safety advisory, 17 August 2026). 2026. tga.gov.au
- US Food and Drug Administration, Center for Drug Evaluation and Research. Multi-discipline review, NDA 210557, Vyleesi (bremelanotide). 2019. accessdata.fda.gov
- Vyleesi (bremelanotide injection), for subcutaneous use. US prescribing information, DailyMed. DailyMed label
- Badenhorst T, Svirskis D, Merrilees M, Bolke L, Wu Z. Effects of GHK-Cu on MMP and TIMP Expression, Collagen and Elastin Production, and Facial Wrinkle Parameters. J Aging Sci 2016. Full text (PDF)
- Wang Y, et al. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. Am J Clin Dermatol 2013. PMID 23417317
- Lintner K, Gerstein F, Solish N. A serum containing vitamins C & E and a matrix-repair tripeptide reduces facial signs of aging as evidenced by Primos analysis and frequently repeated auto-perception. J Cosmet Dermatol 2020;19:3262-3269. PMID 33103342
- SCENESSE (afamelanotide) implant, for subcutaneous use. US prescribing information. Clinuvel Inc. DailyMed, record published 13 May 2026. DailyMed label
- DSM Nutritional Products. SYN-Peptides: SYN-AKE. Product brochure, 2020. DSM brochure
Each figure is as the compound's own sources give it, numbered under References. Where they give none, the list says not stated. The half-life the app draws levels with can differ. Reviewed 17 November 2026.